Healthcare -
Biotechnology - NASDAQ - US
$ 14.25
-4.55 %
$ 2.42 B
Market Cap
-5.52
P/E
IMVT - OPERATING INCOME
Operating Income IMVT - Immunovant, Inc.
-283 M
LAST VALUE
-34.55%
2 YEAR CAGR
-1344.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR